Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Esterases and phosphatases represent two major groups of hydrolase enzymes that catalyze the cleavage of ester and phosphate bonds, respectively, through the addition of water (Satoh & Hosokawa, 2006). Esterases, such as acetylcholinesterase, are vital for terminating neurotransmission and the metabolic breakdown of various drugs and environmental toxins (Soreq & Seidman, 2001). Phosphatases, including protein tyrosine phosphatases and serine/threonine phosphatases, act as critical molecular switches in signal transduction by reversing the actions of kinases (Tonks, 2006). Because these enzymes regulate fundamental cellular processes like growth, metabolism, and signaling, they are significant therapeutic targets in diseases ranging from Alzheimer's to cancer (Hunter, 1995). For example, acetylcholinesterase inhibitors are standard treatments for cognitive symptoms in dementia, while calcineurin phosphatases are targeted for immunosuppression in organ transplantation (Liu et al., 1991). However, the broad distribution and essential nature of these enzymes across different tissues present challenges in drug design, often leading to narrow therapeutic windows and potential off-target toxicity (Satoh & Hosokawa, 2006). Achieving high specificity for particular isoforms is therefore a primary goal in developing drugs that modulate these enzyme classes (Tonks, 2006).
Inhibition of esterase activity to prevent the hydrolysis of esters (e.g., acetylcholine) or inhibition of phosphatase activity to prevent the removal of phosphate groups from protein or lipid substrates.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrolase (Esterase and Phosphatase classes).